Mortality in the United States — Provisional Data, 2023

Link: https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a1.htm?s_cid=mm7331a1_w

Graphic:

FIGURE 1Provisional* number of COVID-19–associated deaths and other deaths and percentage of deaths associated with COVID-19, by week of death — National Vital Statistics System, United States, 2023

* National Vital Statistics System provisional data for 2023 are incomplete. Data from December 2023 are less complete because of reporting lags. These data exclude deaths that occurred in the United States among residents of U.S. territories and foreign countries.

 Deaths with confirmed or presumed COVID-19 as an underlying or contributing cause of death, with International Classification of Diseases, Tenth Revision code U07.1.

Excerpt:

Abstract

Final annual mortality data from the National Vital Statistics System for a given year are typically released 11 months after the end of the calendar year. Provisional data, which are based on preliminary death certificate data, provide an early estimate of deaths before the release of final data. In 2023, a provisional total of 3,090,582 deaths occurred in the United States. The age-adjusted death rate per 100,000 population was 884.2 among males and 632.8 among females; the overall rate, 750.4, was 6.1% lower than in 2022 (798.8). The overall rate decreased for all age groups. Overall age-adjusted death rates in 2023 were lowest among non-Hispanic multiracial (352.1) and highest among non-Hispanic Black or African American persons (924.3). The leading causes of death were heart disease, cancer, and unintentional injury. The number of deaths from COVID-19 (76,446) was 68.9% lower than in 2022 (245,614). Provisional death estimates provide an early signal about shifts in mortality trends. Timely and actionable data can guide public health policies and interventions for populations experiencing higher mortality.

Author(s): Farida B. Ahmad, MPH1; Jodi A. Cisewski, MPH1; Robert N. Anderson, PhD

Publication Date: 8 Aug 2024

Publication Site: CDC, MMWR Morbidity/Mortality Weekly Report

Suggested citation for this article: Ahmad FB, Cisewski JA, Anderson RN. Mortality in the United States — Provisional Data, 2023. MMWR Morb Mortal Wkly Rep 2024;73:677–681. DOI: http://dx.doi.org/10.15585/mmwr.mm7331a1

Achievements in Public Health, 1900-1999: Healthier Mothers and Babies

Link: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4838a2.htm

Graphic:

Excerpt:

Despite the dramatic decline in infant and maternal mortality during the 20th century, challenges remain. Perhaps the greatest is the persistent difference in maternal and infant health among various racial/ethnic groups, particularly between black and white women and infants. Although overall rates have plummeted, black infants are more than twice as likely to die as white infants; this ratio has increased in recent decades. The higher risk for infant mortality among blacks compared with whites is attributed to higher LBW incidence and preterm births and to a higher risk for death among normal birthweight infants (greater than or equal to 5 lbs, 8 oz [greater than or equal to 2500 g]) (18). American Indian/ Alaska Native infants have higher death rates than white infants because of higher SIDS rates. Hispanics of Puerto Rican origin have higher death rates than white infants because of higher LBW rates (19). The gap in maternal mortality between black and white women has increased since the early 1900s. During the first decades of the 20th century, black women were twice as likely to die of pregnancy-related complications as white women. Today, black women are more than three times as likely to die as white women.

During the last few decades, the key reason for the decline in neonatal mortality has been the improved rates of survival among LBW babies, not the reduction in the incidence of LBW. The long-term effects of LBW include neurologic disorders, learning disabilities, and delayed development (20). During the 1990s, the increased use of assisted reproductive technology has led to an increase in multiple gestations and a concomitant increase in the preterm delivery and LBW rates (21). Therefore, in the coming decades, public health programs will need to address the two leading causes of infant mortality: deaths related to LBW and preterm births and congenital anomalies. Additional substantial decline in neonatal mortality will require effective strategies to reduce LBW and preterm births. This will be especially important in reducing racial/ethnic disparities in the health of infants.

Approximately half of all pregnancies in the United States are unintended, including approximately three quarters among women aged less than 20 years. Unintended pregnancy is associated with increased morbidity and mortality for the mother and infant. Lifestyle factors (e.g., smoking, drinking alcohol, unsafe sex practices, and poor nutrition) and inadequate intake of foods containing folic acid pose serious health hazards to the mother and fetus and are more common among women with unintended pregnancies. In addition, one fifth of all pregnant women and approximately half of women with unintended pregnancies do not start prenatal care during the first trimester. Effective strategies to reduce unintended pregnancy, to eliminate exposure to unhealthy lifestyle factors, and to ensure that all women begin prenatal care early are important challenges for the next century.

Author(s): Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.

Publication Date: 1 October 1999

Publication Site: CDC MMWR

Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021

Link:https://www.cdc.gov/mmwr/volumes/70/wr/mm7043e1.htm?s_cid=mm7043e1_w

Graphic:

Excerpt:

What is already known about this topic?

The SARS-CoV-2 B.1.617.2 (Delta) variant is highly transmissible; however, whether it causes more severe disease in adults has been uncertain.

What is added by this report?

Analysis of COVID-NET data from 14 states found no significant increases in the proportion of hospitalized COVID-19 patients with severe outcomes during the Delta period. The proportion of hospitalized unvaccinated COVID-19 patients aged 18–49 years significantly increased during the Delta period.

What are the implications for public health practice?

Lower vaccination coverage in adults aged 18–49 years likely contributed to the increase in hospitalized patients during the Delta period. COVID-19 vaccination is critical for all eligible adults, including adults aged <50 years who have relatively low vaccination rates compared with older adults.

Author(s): Christopher A. Taylor, PhD1; Kadam Patel, MPH1,2; Huong Pham, MPH1; Michael Whitaker, MPH1; Onika Anglin, MPH1,2; Anita K. Kambhampati, MPH1; Jennifer Milucky, MSPH1; Shua J. Chai, MD3,4; Pam Daily Kirley, MPH4; Nisha B. Alden, MPH5; Isaac Armistead, MD5; James Meek, MPH6; Kimberly Yousey-Hindes, MPH6; Evan J. Anderson, MD7,8,9; Kyle P. Openo, DrPH7,8; Kenzie Teno, MPH10; Andy Weigel10; Maya L. Monroe, MPH11; Patricia A. Ryan, MS11; Justin Henderson, MPH12; Val Tellez Nunez, MPH12; Erica Bye, MPH13; Ruth Lynfield, MD13; Mayvilynne Poblete, MA, MPH14; Chad Smelser, MD15; Grant R. Barney, MPH16; Nancy L. Spina, MPH16; Nancy M. Bennett, MD17; Kevin Popham, MPH18; Laurie M. Billing, MPH19; Eli Shiltz, MPH19; Nasreen Abdullah, MD20; Melissa Sutton, MD20; William Schaffner, MD21; H. Keipp Talbot, MD21; Jake Ortega, MPH22; Andrea Price22; Shikha Garg, MD1; Fiona P. Havers, MD1; COVID-NET Surveillance Team

Publication Date: 29 October 2021

Publication Site: MMWR at CDC

COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021

Link:https://www.cdc.gov/mmwr/volumes/70/wr/mm7043e2.htm?s_cid=mm7043e2_w

Excerpt:

What is already known about this topic?

Although deaths after COVID-19 vaccination have been reported to the Vaccine Adverse Events Reporting System, few studies have been conducted to evaluate mortality not associated with COVID-19 among vaccinated and unvaccinated groups.

What is added by this report?

During December 2020–July 2021, COVID-19 vaccine recipients had lower rates of non–COVID-19 mortality than did unvaccinated persons after adjusting for age, sex, race and ethnicity, and study site.

What are the implications for public health practice?

There is no increased risk for mortality among COVID-19 vaccine recipients. This finding reinforces the safety profile of currently approved COVID-19 vaccines in the United States. All persons aged ≥12 years should receive a COVID-19 vaccine.

Author(s): Stanley Xu, PhD1; Runxin Huang, MS1; Lina S. Sy, MPH1; Sungching C. Glenn, MS1; Denison S. Ryan, MPH1; Kerresa Morrissette, MPH1; David K. Shay, MD2; Gabriela Vazquez-Benitez, PhD3; Jason M. Glanz, PhD4; Nicola P. Klein, MD, PhD5; David McClure, PhD6; Elizabeth G. Liles, MD7; Eric S. Weintraub, MPH8; Hung-Fu Tseng, MPH, PhD1; Lei Qian, PhD1

Publication Date: 29 October 2021

Publication Site: MMWR at CDC

COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021

Link:https://www.cdc.gov/mmwr/volumes/70/wr/mm7043e2.htm

Graphic:

Excerpt:

What is already known about this topic?

Although deaths after COVID-19 vaccination have been reported to the Vaccine Adverse Events Reporting System, few studies have been conducted to evaluate mortality not associated with COVID-19 among vaccinated and unvaccinated groups.

What is added by this report?

During December 2020–July 2021, COVID-19 vaccine recipients had lower rates of non–COVID-19 mortality than did unvaccinated persons after adjusting for age, sex, race and ethnicity, and study site.

What are the implications for public health practice?

There is no increased risk for mortality among COVID-19 vaccine recipients. This finding reinforces the safety profile of currently approved COVID-19 vaccines in the United States. All persons aged ≥12 years should receive a COVID-19 vaccine.

Author(s): Stanley Xu, PhD1; Runxin Huang, MS1; Lina S. Sy, MPH1; Sungching C. Glenn, MS1; Denison S. Ryan, MPH1; Kerresa Morrissette, MPH1; David K. Shay, MD2; Gabriela Vazquez-Benitez, PhD3; Jason M. Glanz, PhD4; Nicola P. Klein, MD, PhD5; David McClure, PhD6; Elizabeth G. Liles, MD7; Eric S. Weintraub, MPH8; Hung-Fu Tseng, MPH, PhD1; Lei Qian, PhD1

Publication Date: 22 Oct 2021

Publication Site: CDC

COVID-19 Scenario Modeling Hub: Projections

Link:https://covid19scenariomodelinghub.org/viz.html

Graphic:

Excerpt:

Definitions

NPI: NonPharmaceutical Interventions (e.g. masks, social distancing)
Epiweek: Epidemiological Week as defined by MMWR
LOP: Linear Opinion Pool; method used to calculate Ensemble_LOP and Ensemble_LOP_untrimmed by averaging cumulative probabilities of a given value across submissions. See Notes for more details.

Publication Date: Accessed 24 Sept 2021

Publication Site: COVID-19 Scenario Modeling Hub

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021

Link: https://www.cdc.gov/mmwr/volumes/70/wr/mm7037e1.htm?s_cid=mm7037e1_w

Graphic:

Excerpt:

Averaged weekly, age-standardized rates (events per 100,000 persons) were higher among persons not fully vaccinated than among fully vaccinated persons for reported cases (112.3 versus 10.1), hospitalizations (9.1 versus 0.7), and deaths (1.6 versus 0.1) during April 4–June 19, as well as during June 20–July 17 (89.1 versus 19.4; 7.0 versus 0.7; 1.1 versus 0.1, respectively). Higher hospitalization and death rates were observed in older age groups, regardless of vaccination status, resulting in a larger impact of age-standardization on overall incidence for these outcomes.

Within each age group, the percentage of vaccinated persons among cases, hospitalizations, and deaths increased with increasing vaccination coverage (Figure 1). As the prevalence of SARS-CoV-2 Delta variant surpassed 50%, the percentage of vaccinated persons among cases in each age group increased at rates corresponding to benchmarks for lower VE (i.e., from approximately 90% to <80%). Increases in the percentages of vaccinated persons aged ≥65 years among COVID-19–associated hospitalizations and deaths also appeared higher than expected. During June 20–July 17, age-standardized rates of cases, hospitalizations, and deaths among persons not fully vaccinated increased weekly; among fully vaccinated persons, case rates increased, but rates of hospitalizations and deaths remained largely unchanged (Figure 2).

Author(s): Heather M. Scobie, PhD1; Amelia G. Johnson, DrPH1; Amitabh B. Suthar, PharmD2; Rachel Severson, MS3; Nisha B. Alden, MPH3; Sharon Balter, MD4; Daniel Bertolino, MPH5; David Blythe, MD6; Shane Brady, MPH7; Betsy Cadwell, MSPH1; Iris Cheng, MS5; Sherri Davidson, PhD8; Janelle Delgadillo9; Katelynn Devinney, MPH5; Jeff Duchin, MD10; Monique Duwell, MD6; Rebecca Fisher, MPH4; Aaron Fleischauer, PhD11; Ashley Grant, MPH12; Jennifer Griffin, PhD4; Meredith Haddix, MPH4; Julie Hand, MSPH12; Matt Hanson, MD10; Eric Hawkins, MS13; Rachel K. Herlihy, MD3; Liam Hicks, MPH7; Corinne Holtzman, MPH14; Mikhail Hoskins, MPH11; Judie Hyun, MHS6; Ramandeep Kaur, PhD8; Meagan Kay, DVM10; Holly Kidrowski, MPH14; Curi Kim, MSPH6; Kenneth Komatsu, MPH7; Kiersten Kugeler, PhD1; Melissa Lewis, MPH1; B. Casey Lyons, MPH2; Shelby Lyons, MPH12; Ruth Lynfield, MD14; Keegan McCaffrey7; Chelsea McMullen, MS15; Lauren Milroy, MPH13; Stephanie Meyer, MPH14; Leisha Nolen, MD9; Monita R. Patel, PhD1; Sargis Pogosjans, MPH10; Heather E. Reese, PhD1; Amy Saupe, MPH14; Jessica Sell, MPH5; Theresa Sokol, MPH12; Daniel Sosin, MD15; Emma Stanislawski, MPH15; Kelly Stevens, MS8; Hailey Vest, MPH13; Kelly White, MPH13; Erica Wilson, MD11; Adam MacNeil, PhD1; Matthew D. Ritchey2; Benjamin J. Silk, PhD1

Publication Date: 10 Sept 2021

Publication Site: CDC, Morbidity and Mortality Weekly Report